1-4 of 4
Sanjay Goel, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Older Age and Increased Neutrophil-to-Lymphocyte Ratio (NLR) Are Predictors of Mortality in a Multiethnic Urban Cohort of Hematologic Neoplasms and COVID-19 Patients

Angelica D'Aiello, Sumaira Zareef, MD, Kith Pradhan, PhD, Amanda Lombardo, PA-C, BS, MS, Fariha Khatun, PA-C, Jennat Mustafa, PA-C, Alyssa De Castro, PharmD, Felisha Joseph, PA-C, Kailyn Gillick, PA-C, Anjali Naik, PA-C, Astha Thakkar, MBBS, Lauren C Shapiro, MD, Shafia Rahman, MD, Zhu Cui, MD, Jesus D Gonzalez Lugo, MD, Fiona Mienko, MBBS, Numa Tarnima Rahman, MD, Robert Lopez, MD, Heidi Chwan Ko, DO, Amanda Podolski, MD, Vikas Mehta, MD, Sanjay Goel, MD, Rafi Kabarriti, MD, Joseph Sparano, MD, Stuart Packer, MD, David Lawrence Fernandes, MD, Enrico Castelucci, MD, Margarita Kushnir, MD, Mark Chaitowitz, MD, Luca Paoluzzi, MD, Ulrich G. Steidl, MDPhD, Phaedon Zavras, MD, Ioannis Mantzaris, MD MS, Noah Kornblum, MD, Aditi Shastri, MD, Lizamarie Bachier-Rodriguez, MD, Kira Gritsman, MDPhD, Henny H. Billett, MD MSc, Rachel Bartash, MD, Yoram Puius, MD PhD, Margaret Mccort, MD, Ira Braunschweig, MD, Mendel Goldfinger, MD, Amit Verma, MBBS, R. Alejandro Sica, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 34–35.
https://doi.org/10.1182/blood-2020-138842
Published: 2020
Journal Articles

Preliminary Results of the Stapled Peptide ALRN-6924, a Dual Inhibitor of MDMX and MDM2, in Two Phase IIa Dose Expansion Cohorts in Relapsed/Refractory TP53 Wild-Type Peripheral T-Cell Lymphoma

Andrei R. Shustov, MD, Steven M. Horwitz, MD, Jasmine Zain, MD, Manish R Patel, MD, Sanjay Goel, MD, Lubomir Sokol, MD PhD, Funda Meric-Bernstam, MD, Geoffrey Shapiro, MD PhD, Sunita Dwivedy Nasta, MD, Murali Janakiram, MD MS, David M Weinstock, MD, Ronald Korn, MD PhD, Marie Payton, MBA, D. Allen Annis, PhD, Dawn Pinchasik, MD, Manuel Aivado, MD PhD, Amitkumar Mehta, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1623.
https://doi.org/10.1182/blood-2018-99-116780
Published: 2018
Journal Articles

A 2-Part Phase I Study in Patients with Solid or Hematologic Malignancies: Dose Proportionality of Subcutaneous (SC) Azacitidine (AZA) and Pharmacokinetics of SC AZA in Patients with Severe Renal Impairment,

Eric Laille, MS, Alain C. Mita, MD, Sanjay Goel, MD, MS, Nashat Y. Gabrail, MD, Joseph Schwarz, MBA, CL Beach, PharmD
Journal: Blood
Blood (2011) 118 (21): 3480.
https://doi.org/10.1182/blood.V118.21.3480.3480
Published: 2011
Journal Articles

Safety, Tolerability, and Pharmacokinetic Assessment of CG53135 Administered Intravenously in Patients with Advanced (Stage 4) Cancer (Single Rising-Dose Tolerance).

Joe Stephenson, MD, Sanjay Goel, MD, Pankaj Bhargava, MD, Saroj Vadhan-Raj, MD, Vincent Annino, Thomas Hawthorne, PhD, Yuan-Di Halvorsen, PhD, William Hahne, MD
Journal: Blood
Blood (2004) 104 (11): 5030.
https://doi.org/10.1182/blood.V104.11.5030.5030
Published: 2004